Investigators set out to determine how sex, racial and ethnic, and geographic disparities affect treatment timeliness for patients with colorectal cancer.
Meta-analysis of data from FDA trials shows significantly improved OS, PFS, but increased risk for grade ≥3 adverse events compared with men ...
Wastewater-based epidemiology is feasible as a community-level and population-level surveillance tool for colorectal cancer (CRC), according to a study published online March 17 in the Journal of ...
In this study, researchers aimed to determine whether the addition of durvalumab to gemcitabine plus cisplatin increases time toxicity.
Among women using medically assisted reproduction (MAR), the overall incidence of cancer was comparable to that of the general population, according to a study published online March 10 in JAMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results